ArticleNeurology and therapy2026

Safety and Effectiveness of Inebilizumab in Patients with Neuromyelitis Optica Spectrum Disorder: Interim Analysis of a Post-marketing Surveillance in Japan.

Kazuo Fujihara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.